The observed expression of DNMT1 in cancer tissues increased progressively with disease stage progression, consistent with previous reports showing that DNMT1 expression correlated with high stage breast cancers.[43, 44] This patten also aligned with DNMT1 activity levels in patient plasma. This evidence concerns the gene DNMT1 and breast carcinoma.